Smith Salley Wealth Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
LP
Smith Salley Wealth Management's AGN Position: Q1 2019 in Review
Smith Salley Wealth Management sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 24,275 shares — an estimated $3.24M sold.
Smith Salley Wealth Management first reported a position in AGN in Q1 2015 and held it in 16 quarters. The position peaked at $8.02M in Q2 2017. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.
- Smith Salley Wealth Management reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
- Smith Salley Wealth Management sold 24,275 Allergan plc shares in Q1 2019, an estimated $3.24M.
- Smith Salley Wealth Management first reported a position in Allergan plc in Q1 2015 and held it in 16 quarters.
- Smith Salley Wealth Management's Allergan plc position peaked at $8.02M in Q2 2017.
- 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.
Based on Smith Salley Wealth Management's 13F filing for Q1 2019, filed 3 May 2019.